Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma

por Pinton, Giulia, Moro, Laura
Publicado 2017

Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality

por Pinton, Giulia, Nilsson, Stefan, Moro, Laura
Publicado 2018

Clinical and genetic characterization of a Chanarin Dorfman Syndrome patient born to diseased parents

por Durdu, Murat, Missaglia, Sara, Moro, Laura, Tavian, Daniela
Publicado 2018

Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency

por Missaglia, Sara, Tavian, Daniela, Moro, Laura, Angelini, Corrado
Publicado 2018

Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review

por Pinton, Giulia, Manzotti, Beatrice, Balzano, Cecilia, Moro, Laura
Publicado 2021

Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma

por Al Khatib, MHD Ouis, Pinton, Giulia, Moro, Laura, Porta, Chiara
Publicado 2023

Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition

por Ayinde, Oluseyi, Wang, Zhuo, Pinton, Giulia, Moro, Laura, Griffin, Martin
Publicado 2019

Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma

por Pinton, Giulia, Manente, Arcangela Gabriella, Angeli, Giovanni, Mutti, Luciano, Moro, Laura
Publicado 2012

A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings

por Eskiocak, Ali Haydar, Missaglia, Sara, Moro, Laura, Durdu, Murat, Tavian, Daniela
Publicado 2019

The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH(3)COO)Cl(2)(NH(3))(2)(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to...

por Gabano, Elisabetta, Zanellato, Ilaria, Pinton, Giulia, Moro, Laura, Ravera, Mauro, Osella, Domenico
Publicado 2022

PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1

por Pinton, Giulia, Manente, Arcangela Gabriella, Murer, Bruno, Marino, Elvira, Mutti, Luciano, Moro, Laura
Publicado 2013

Coordinated Sumoylation and Ubiquitination Modulate EGF Induced EGR1 Expression and Stability

por Manente, Arcangela Gabriella, Pinton, Giulia, Tavian, Daniela, Lopez-Rodas, Gerardo, Brunelli, Elisa, Moro, Laura
Publicado 2011

Unsymmetric Cisplatin-Based Pt(IV) Conjugates Containing a PARP-1 Inhibitor Pharmacophore Tested on Malignant Pleural Mesothelioma Cell Lines

por Gabano, Elisabetta, Pinton, Giulia, Balzano, Cecilia, Boumya, Sara, Osella, Domenico, Moro, Laura, Ravera, Mauro
Publicado 2021

Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity

por Pinton, Giulia, Manente, Arcangela G, Daga, Antonio, Cilli, Michele, Rinaldi, Maurizio, Nilsson, Stefan, Moro, Laura
Publicado 2014

Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells

por Manente, Arcangela G., Pinton, Giulia, Zonca, Sara, Cilli, Michele, Rinaldi, Maurizio, Daga, Antonio, Nilsson, Stefan, Moro, Laura
Publicado 2015

Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia

por Zonca, Sara, Pinton, Giulia, Wang, Zhuo, Soluri, Maria Felicia, Tavian, Daniela, Griffin, Martin, Sblattero, Daniele, Moro, Laura
Publicado 2017

Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter

por Missaglia, Sara, Valadares, Eugenia Ribeiro, Moro, Laura, Faguntes, Eleonora Druve Tavares, quintão Roque, Raquel, Giardina, Bruno, Tavian, Daniela
Publicado 2014

Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib

por Pinton, Giulia, Thomas, Warren, Bellini, Paolo, Manente, Arcangela Gabriella, Favoni, Roberto E., Harvey, Brian J., Mutti, Luciano, Moro, Laura
Publicado 2010

CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition

por Pinton, Giulia, Wang, Zhuo, Balzano, Cecilia, Missaglia, Sara, Tavian, Daniela, Boldorini, Renzo, Fennell, Dean A., Griffin, Martin, Moro, Laura
Publicado 2021

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition

por Pinton, Giulia, Wang, Zhuo, Balzano, Cecilia, Missaglia, Sara, Tavian, Daniela, Boldorini, Renzo, Fennell, Dean A., Griffin, Martin, Moro, Laura
Publicado 2022